ClinicalTrials.Veeva

Menu

Shortystrap Effectiveness in the Treatment of the Pathology Pubic and Abdominal Pathology in Athletes

R

Rennes University Hospital

Status and phase

Completed
Phase 2

Conditions

Pubic and Abdominal Pathology

Treatments

Other: Shortystrap

Study type

Interventional

Funder types

Other

Identifiers

NCT02882399
2012-A01172-41
35RC12_8971 (Other Identifier)

Details and patient eligibility

About

The pubic and abdominal pathology is common among athletes. It leads to a shutdown of physical activity for several months, and requires rehabilitative care, or surgery for a permanent cure. Shortystrap is designed to avoid surgery and allow the continuation of sports.

Enrollment

49 patients

Sex

Male

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Male
  • Sports practicing physical activity at least 3 hours per week
  • Practicing a team sport with a major part of running (football, rugby, ...)
  • Presenting a pubic and abdominal pathology for at least 4 weeks
  • In primary consultation
  • Age from 18 to 40 years
  • Informed consent signed

Exclusion criteria

  • Professional athlete
  • Cyclist
  • Having already received usual medical treatment (anti-inflammatory treatment and rest)
  • Introducing another disease requiring treatment with NSAIDs
  • Allergy neoprene
  • Contraindications to performing MRI (claustrophobia, any metal device, pacemaker, etc.)
  • Simultaneous participation in another biomedical research
  • Major person under legal protection (backup justice, trusteeship, guardianship), person deprived of liberty.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

49 participants in 1 patient group

Shortystrap
Experimental group
Treatment:
Other: Shortystrap

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems